Frontiers in Clinical Drug Research Anti-Cancer Agents/ (Record no. 157667)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01481nam a2200217Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220322140649.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210614s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-981-14-0514-3 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 981140514X |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | LC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Atta-ur-Rahman, FRS |
| Relator code | Editor |
| 245 #0 - TITLE STATEMENT | |
| Title | Frontiers in Clinical Drug Research Anti-Cancer Agents/ |
| Statement of responsibility, etc | Atta-ur-Rahman, FRS |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | UAE: |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Name of publisher, distributor, etc | Bentham Science Publisher, |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc | 2019. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 187 pages |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Volume number/sequential designation | Vol. 5 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.<br/><br/>The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Book |
| Source of classification or shelving scheme | Library of Congress Classification |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | 22/03/2022 | RM301.27.F76_2019 | P 2981 | 22/03/2022 | 22/03/2022 | Book |